← Volver a la portada
Asia · Mercados regionales · Vietnam Investment Review

MSD and VNVC step towards technology transfer, manufacturing, and localisation of vaccine technology

Publicado por Vietnam Investment Review · Vietnam hace 9 h
MSD and VNVC step towards technology transfer, manufacturing, and localisation of vaccine technology
MSD and VNVC step towards technology transfer, manufacturing, and localisation of vaccine technology · Vietnam Investment Review

Resumen detallado

On November 18, MSD and Vietnam Vaccine JSC (VNVC) announced plans to collaborate on the technology transfer, manufacturing, and localisation of a vaccine technology product.

The event saw the presence of Minister of Health Dao Hong Lan, Deputy Minister of Science and Technology Le Xuan Dinh, Deputy Minister of Foreign Affairs Dang Hoang Giang, and representatives of government agencies.

The announcement marks a key milestone during the visit of MSD’s senior leadership team to Vietnam, laying the groundwork for further steps towards the long-term transfer of scientific knowledge, technical expertise, quality processes, and manufacturing capabilities to VNVC.

"MSD looks forward to bringing more than 130 years of global expertise to this planned partnership. We are equally encouraged by VNVC’s local leadership, investment, and long-term vision. By combining our respective strengths, we hope to support stronger disease prevention efforts and deliver lasting benefits for the health of the Vietnamese people,” said Marc Gailhardou, president of MSD’s Intercontinental Region.

Ngo Chi Dung, VNVC’s chairman and CEO, said, “For many years, VNVC has worked closely with MSD to bring millions of vaccine doses to people in Vietnam each year. Building on this successful collaboration, the two parties are working toward a strategic cooperation plan covering technology transfer, manufacturing, and localisation of strategic vaccine technology product, contributing to Vietnam’s vision of advancing science and technology and strengthening healthcare self-reliance.”

“VNVC views high-tech vaccine manufacturing a long-term strategy that requires significant investment in technology, human resources, and quality management. We have invested in the development of a modern manufacturing facility and are building the foundation to receive and progressively master advanced technologies.

Later that day, MSD leaders also met with Deputy Prime Minister Pham Thi Thanh Tra. The discussions focused on Vietnam’s healthcare priorities, the role of science, technology, and innovation in advancing healthcare, and opportunities to strengthen collaboration between the government…

Du…

Inicio del artículo, extracto de Vietnam Investment Review. Para leer el resto, abra el artículo en el sitio del medio.

Leer el artículo completo en Vietnam Investment Review Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (vir.com.vn)

También te puede interesar